Stock Events

Acadia Pharmaceuticals (ACAD) Q1 2016 Earnings

29FebConfirmed
Q2 2015
Q3 2015
Q4 2015
Q1 2016
-0.45
-0.39
-0.34
-0.28

Details

Expected EPS
-0.38
Actual EPS
-0.45
Surprise EPS
-0.07
Surprise Percent
+18.42%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.45 per share for Q1 2016.

0 Comments

Share your thoughts